Apyx Medical Corporation
APYX
$3.63
-$0.06-1.63%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 48.82% | 13.22% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 48.82% | 13.22% | |||
| Cost of Revenue | 56.44% | 6.76% | |||
| Gross Profit | 44.62% | 17.14% | |||
| SG&A Expenses | 32.61% | -5.72% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 39.71% | -1.71% | |||
| Operating Income | 101.32% | 67.68% | |||
| Income Before Tax | 38.95% | 49.12% | |||
| Income Tax Expenses | 20.51% | 59.18% | |||
| Earnings from Continuing Operations | 36.57% | 47.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -103.45% | 27.50% | |||
| Net Income | 34.53% | 47.49% | |||
| EBIT | 101.32% | 67.68% | |||
| EBITDA | 134.73% | 72.65% | |||
| EPS Basic | 36.76% | 47.52% | |||
| Normalized Basic EPS | 37.63% | 48.78% | |||
| EPS Diluted | 36.76% | 47.52% | |||
| Normalized Diluted EPS | 37.63% | 48.78% | |||
| Average Basic Shares Outstanding | 3.47% | 0.05% | |||
| Average Diluted Shares Outstanding | 3.47% | 0.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||